Mechanistic study demonstrates that anthraquinone surface ligands boost carbon dioxide photoreduction on perovskite nanocrystals, highlighting molecular electric-field regulation.
Halide perovskite nanocrystals are promising photocatalysts for CO2 reduction due to their strong light absorption, defect tolerance, and tunable excited-state properties, but their practical performance remains limited by tightly bound excitons, rapid charge recombination, and inefficient interfacial electron delivery. Here, we report an anthraquinone (AQ)-modified CsPbBr3 nanocrystal photocatalyst (CPB/AQ) in which the redox-active π-conjugated AQ ligand functions as an interfacial electron relay and molecular electric-field modulator. Experimental and theoretical analyses collectively reveal that AQ creates an additional interfacial charge-transfer pathway, strengthens the light-induced surface potential difference from 170 to 270 mV, and decreases the exciton binding energy from 44.05 to 40.74 meV. Consequently, CPB/AQ achieves a CO yield of 433.50 μmol g–1 within 3 h under AM 1.5G irradiation, 4.54 times that of pristine CPB, and maintains stable CO evolution during a 25 h test. Isotopic 13CO2 tracing verifies that CO originates from CO2 reduction, while in situ FTIR spectroscopy demonstrates enhanced CO2 adsorption/activation and accelerated formation of *COOH and *CO intermediates on CPB/AQ. This work highlights molecularly gated interfacial electric-field regulation as an effective strategy for overcoming charge-transfer bottlenecks in perovskite nanocrystal photocatalysis.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: